The FDA has approved the first new class of schizophrenia drug in 70 years Australian science contributed to the discovery of ...
The US FDA has approved a new drug, Cobenfy, for treating schizophrenia in adults. This is a first new class for medication ...
US regulators have approved a new treatment for schizophrenia, the first of its kind targeting the mental condition in ...
The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for the treatment of ...
On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.
The U.S. Food and Drug Administration approved a new drug for the treatment of schizophrenia in adults. Dr. Darien Sutton explains.
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
FARGO, N.D. (Valley News Live) - Changes are coming to the way schizophrenia is treated. The US Food and Drug Administration ...
Cobenfy is the first schizophrenia drug in decades to treat the mental health condition in a new way, with potentially fewer ...
Recent research is painting a clearer picture of the link between the use of clozapine for schizophrenia and respiratory ...
The FDA approved a new drug for schizophrenia. Discrimination is stressing Chinese Americans and damaging their mental health.
The US Food and Drug Administration (FDA) has approved xanomeline and trospium chloride capsules (Cobenfy) for the treatment of schizophrenia in adults. The drug is the first antipsychotic treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback